| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.012 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0047 | 1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |